Key Highlights
- Rocket Lab secured a new multi-launch agreement with iQPS covering three additional Electron missions beginning in 2028.
- The partnership between the two entities now encompasses 15 missions, with seven launches successfully completed since 2023.
- Within a six-month period, iQPS has placed two separate multi-launch orders with Rocket Lab.
- Wall Street maintains a Moderate Buy rating on RKLB with an average price target reaching $86.77, suggesting approximately 30% growth potential.
- The upcoming Neutron rocket program, anticipated to debut between late 2026 and early 2027, represents a major growth opportunity.
Rocket Lab has successfully secured another series of missions with a long-standing customer, drawing considerable attention from financial analysts who are evaluating whether the company can convert its operational momentum into improved profitability.
The aerospace company revealed a fresh multi-launch partnership with the Institute for Q-shu Pioneers of Space (iQPS) covering three more Electron rocket flights. These missions will commence no sooner than 2028, with liftoffs occurring from Launch Complex 1 located in New Zealand.
This agreement elevates the combined mission tally between the organizations to 15. The partnership has already executed seven successful flights starting from 2023.
What stands out is that iQPS has now committed to two separate multi-launch contracts with Rocket Lab within a half-year timeframe. Such continued patronage demonstrates strong confidence in operational performance and delivery consistency.
The upcoming missions will carry QPS-SAR satellites into orbit utilizing Rocket Lab’s Motorized Lightband separation technology. Each flight will be entirely dedicated to carrying iQPS spacecraft.
Brian Rogers, Vice President of Global Launch Services at Rocket Lab, emphasized that the partnership’s strength stems from reliable execution across previous missions. The company’s next scheduled iQPS launch is planned for no earlier than May 2026.
In recent financial activities, Rocket Lab completed its at-the-market equity offering, generating approximately $474 million in gross proceeds. The organization also maintains collared forward transaction agreements with potential maximum proceeds reaching $642 million.
Regarding corporate expansion, Rocket Lab obtained German regulatory clearance for its proposed acquisition of Mynaric. The transaction is projected to finalize in April with a valuation near $75 million.
Neutron Development Takes Center Stage
Trailing twelve-month revenue reached $601.8 million, representing a 38% year-over-year increase. However, industry analysts emphasize that the more significant narrative centers on future prospects, particularly Neutron.
The 43-meter partially reusable launch vehicle is engineered to rival SpaceX’s Falcon 9 in the satellite deployment and cargo transport sectors. Critical elements, including the “Hungry Hippo” fairing system and thrust structure, have reached readiness for final integration.
Clear Street analyst Gregory Pendy noted that Neutron could access a substantially larger market segment while delivering increased revenue per mission compared to Electron, positioning it as a primary growth engine assuming development milestones are met on schedule.
Wall Street Perspective
Citizens analyst Trevor J. Walsh elevated RKLB from Hold to Buy this week, maintaining an $85 price objective. Walsh identified the current valuation as an opportune entry level and emphasized Rocket Lab’s strategic expansion into defense contracting and comprehensive space services as avenues toward enhanced profit margins.
Sujeeva De Silva from Roth MKM sustained a Buy recommendation with a $90 target. De Silva called attention to Rocket Lab’s expanding order backlog and its diversification into satellite component manufacturing as proof the organization is successfully broadening beyond launch services alone.
Overall, RKLB maintains a Moderate Buy consensus rating on TipRanks, with 10 Buy ratings and 5 Hold ratings issued during the past three months. The mean price target stands at $86.77, indicating potential upside of approximately 30% from present trading levels.
RKLB shares declined 3.39% on the day the announcement was made.
